Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis

Strongyloidiasis, caused by the nematode Strongyloides stercoralis, remains a threat to global public health. To date, a vaccine against strongyloidiasis remains unavailable and there was no significant development in this area after discovering the potential of recombinant protein Ss-IR as a vaccin...

Full description

Bibliographic Details
Main Author: Wong, Matthew Tze Jian
Format: Thesis
Language:English
Published: 2024
Subjects:
Online Access:http://eprints.usm.my/63148/
Abstract Abstract here
_version_ 1855630889991536640
author Wong, Matthew Tze Jian
author_facet Wong, Matthew Tze Jian
author_sort Wong, Matthew Tze Jian
description Strongyloidiasis, caused by the nematode Strongyloides stercoralis, remains a threat to global public health. To date, a vaccine against strongyloidiasis remains unavailable and there was no significant development in this area after discovering the potential of recombinant protein Ss-IR as a vaccine candidate in 2011. In light of recent developments in the diagnosis of strongyloidiasis, A133 emerged in 2021 as an excellent diagnostic antigen, prompting curiosity for its potential as a vaccine candidate. Therefore, this study aimed to evaluate the efficacy of recombinant protein A133 in comparison to Ss-IR, as a potential vaccine candidate against S. stercoralis by investigating humoral and cellular immune responses in immunised mice.
first_indexed 2025-12-24T00:13:41Z
format Thesis
id usm-63148
institution Universiti Sains Malaysia
language English
last_indexed 2025-12-24T00:13:41Z
publishDate 2024
record_format EPrints
record_pdf Restricted
spelling usm-631482025-10-30T08:03:58Z http://eprints.usm.my/63148/ Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis Wong, Matthew Tze Jian R5-920 Medicine (General) Strongyloidiasis, caused by the nematode Strongyloides stercoralis, remains a threat to global public health. To date, a vaccine against strongyloidiasis remains unavailable and there was no significant development in this area after discovering the potential of recombinant protein Ss-IR as a vaccine candidate in 2011. In light of recent developments in the diagnosis of strongyloidiasis, A133 emerged in 2021 as an excellent diagnostic antigen, prompting curiosity for its potential as a vaccine candidate. Therefore, this study aimed to evaluate the efficacy of recombinant protein A133 in comparison to Ss-IR, as a potential vaccine candidate against S. stercoralis by investigating humoral and cellular immune responses in immunised mice. 2024-02 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/63148/1/Pages%20from%20MATTHEW%20WONG%20TZE%20JIAN%20-%20TESIS.pdf Wong, Matthew Tze Jian (2024) Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis. PhD thesis, Universiti Sains Malaysia.
spellingShingle R5-920 Medicine (General)
Wong, Matthew Tze Jian
Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis
thesis_level PhD
title Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis
title_full Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis
title_fullStr Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis
title_full_unstemmed Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis
title_short Immunogenicity Evaluation Of A133 And Ss-Ir: Development Of Vaccine Candidates Against Strongyloides Stercoralis
title_sort immunogenicity evaluation of a133 and ss ir development of vaccine candidates against strongyloides stercoralis
topic R5-920 Medicine (General)
url http://eprints.usm.my/63148/
work_keys_str_mv AT wongmatthewtzejian immunogenicityevaluationofa133andssirdevelopmentofvaccinecandidatesagainststrongyloidesstercoralis